Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Perit Dial Int ; 42(5): 535-539, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35352596

RESUMEN

The Covid-19 pandemic has been responsible for millions of deaths worldwide. Patients with comorbidities- such as those on peritoneal dialysis (PD)- present higher morbidity and mortality than the general population. We prospectively evaluated all Chilean patients on PD (48 centres) and followed those who had Covid-19 from the beginning of the Covid-19 pandemic in Chile (March 2020) to January 2021 (start of vaccination campaign). We described demographic history, comorbidities, factors related to infection, need for hospitalisation and death due to Covid-19. During the study period, 106 adults on PD were infected by SARS-CoV-2, with a mean age of 53.1 (±16.3) and of which 53.9% were female. From that group, 54.8% required hospitalisation and 24.5% (n = 26) died due to Covid-19. Most of the patients (63.4%) were infected at home and 22.8% during hospitalisation for other reasons. There was a significant association for Covid-19 mortality with: being ≥60 years old, diabetes, time on PD ≥5 years, need for hospitalisation and hospital-acquired infection. At 90 days of follow-up, all deaths associated to Covid-19 occurred before 40 days. We conclude that patients on PD without Covid-19 vaccination have a high mortality and need for hospitalisation associated to Covid-19. To avoid this negative outcome, it is necessary to intensify strategies to avoid contagion, especially in those ≥60 years old, with diabetes and/or ≥5 years spent on PD.


Asunto(s)
COVID-19 , Diabetes Mellitus , Diálisis Peritoneal , Adulto , COVID-19/terapia , Vacunas contra la COVID-19 , Chile/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pandemias , SARS-CoV-2
2.
Am J Orthop (Belle Mead NJ) ; 36(6): 308-13, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17643145

RESUMEN

When a professional athlete injures an elbow or shoulder, the uninjured joint must receive as much attention as the injured joint. Is there a relationship between injury of one joint and subsequent injury of the other joint? In the prospective study reported here, we created a database (a) to determine whether injury to one joint was more likely to result in a problem with the other joint and (b) to analyze for trends and correlations. A survey was administered to all pitchers on a professional baseball team to collect data about shoulder and elbow problems during their careers. Eighty-four pitchers (737 seasons of experience, 52 index injuries) were evaluated. Of the injured players, 27 were treated surgically. Risk for later injury was 4.6 times larger for players who had an index surgery than for those who had not. Of the players who had ulnar collateral ligament (UCL) reconstruction, 42% later sustained a shoulder injury. No player with rotator cuff surgery sustained a subsequent elbow or shoulder injury. There were significantly more upper extremity injuries with right-handed throwers. An elbow injury was more likely to result in shoulder problems, specifically after UCL reconstruction. Players who required surgery were almost 5 times more likely to have a later injury or surgery than players who did not require surgery.


Asunto(s)
Traumatismos en Atletas/diagnóstico , Béisbol/lesiones , Lesiones de Codo , Lesiones del Hombro , Adolescente , Adulto , Articulación del Codo/cirugía , Humanos , Masculino , Estudios Prospectivos , Articulación del Hombro/cirugía , Resultado del Tratamiento
3.
Nephrol Dial Transplant ; 19(10): 2505-12, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15280531

RESUMEN

BACKGROUND: Nuclear factor-kappaB (NF-kappaB) regulates genes involved in renal disease progression, such as the chemokines monocyte chemoattractant protein-1 (MCP-1) and RANTES. NF-kappaB is activated in experimental models of renal injury, and in vitro studies also suggest that proteinuria and angiotensin II could be important NF-kappaB activators. It has been proposed that locally produced MCP-1 may be involved in the development of diabetic nephropathy (DN). We examined the hypothesis that NF-kappaB could be an indicator of renal damage progression in DN. METHODS: Biopsy specimens from 11 patients with type 2 diabeties and overt nephropathy were studied by southwestern histochemistry for the in situ detection of activated NF-kappaB. In addition, by immunohistochemistry and/or in situ hybridization, we studied the expression of MCP-1 and RANTES, whose genes are regulated by NF-kappaB. RESULTS: NF-kappaB was detected mainly in cortical tubular epithelial cells and, to a lesser extent, in some glomerular and interstitial cells. A strong upregulation of MCP-1 and RANTES was observed in all the cases, mainly in tubular cells, and there was a strong correlation between the expression of these chemokines and NF-kappaB activation in the same cells, as observed in serial sections (r = 0.7; P = 0.01). In addition, the tubular expression of these chemokines was correlated mainly with the magnitude of the proteinuria (P = 0.002) and with interstitial cell infiltration (P<0.05). CONCLUSIONS: The activation of NF-kappaB and the transcription of certain pro-inflammatory chemokines in tubular epithelial cells are markers of progressive DN. Proteinuria might be one of the main factors inducing the observed pro-inflammatory phenotype.


Asunto(s)
Quimiocina CCL2/metabolismo , Quimiocina CCL5/metabolismo , Nefropatías Diabéticas/metabolismo , FN-kappa B/metabolismo , Adulto , Biomarcadores/metabolismo , Quimiocina CCL2/genética , Quimiocina CCL5/genética , Diabetes Mellitus Tipo 2/complicaciones , Nefropatías Diabéticas/etiología , Nefropatías Diabéticas/genética , Nefropatías Diabéticas/patología , Progresión de la Enfermedad , Femenino , Expresión Génica , Regulación de la Expresión Génica , Humanos , Inmunohistoquímica , Hibridación in Situ , Inflamación/patología , Riñón/metabolismo , Riñón/patología , Masculino , Persona de Mediana Edad , Subunidad p50 de NF-kappa B , ARN Mensajero/metabolismo , Factor de Transcripción ReIA , Regulación hacia Arriba
4.
Bull. W.H.O. (Print) ; 45(3): 275-278, 1971.
Artículo en Inglés | WHO IRIS | ID: who-262678
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA